Safety Profile of Guselkumab in Treatment of Patients with Psoriasis and Coexisting Hepatitis B or C: A Multicenter Prospective Cohort Study_Supplemental Materials
Published: 15 January 2024| Version 1 | DOI: 10.17632/6mfskzbx64.1
Contributors:
Yu-Huei Huang, Ju-Shao Yen , Shu-Hao Li, Hsien-Yi ChiuDescription
Supplementary Table 1 and Supplementary Table 2.
Files
Institutions
- National Taiwan University Hospital Hsin-Chu Branch
Categories
Dermatology, Biologic Agent, Hepatitis B, Hepatitis C, Psoriasis
Funders
- National Taiwan University Hospital Hsin-Chu BranchTaiwanGrant ID: 112-HCH092, 112-HCH065
- National Science and Technology CouncilTaiwanGrant ID: MOST 109-2314-B-182A-012, MOST 110-2314-B-182A-104, and MOST111-2314-B-182A-116, MOST 111-2314-B-002-244